As CRISPR genome editing struggles to overcome key specificity and delivery challenges in its pursuit to realize therapeutic applications, the 2nd RNA Editing Summit returns to help you accelerate the translation and commercialization of RNA editing for an array of research and therapeutic applications. This virtual conference focuses specifically on the latest approaches in RNA-editing...
Piper Sandler conferences and events are by invitation only. If you wish to attend, please contact your Piper Sandler representative.
CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. KEYNOTES FOR 2020! Patient Perspective — Chasing My Cure David Fajgenbaum, MD Technology Spotlight — Using AI to Speed Discovery of New Treatments Tim Guilliams Scientific Luminary —...
Join BIO and LaVoieHealthScience for our next Global Market View webinar on December 1 at 10:30AM ET. Our panel of industry leaders with share their perspectives on several topics including private, public, US, EU and China markets, JPM virtual week, the 2020 election, new company formation, year-end regulatory reviews and record financing through NewCo IPO's,...
MassBio’s President & CEO, Bob Coughlin, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions, hear what MassBio is up to, and learn more about the state of the industry amidst the COVID-19 pandemic. This Town Hall will feature Matthew Harrison, a Managing Director and...
The prospect of raising capital for early stage companies (pre-seed to Series A) in times of uncertainty always present challenges. Funders continue to invest in companies they have worked with previously, but for the first time entrepreneur or the novice team attracting the right type of capital, the process is longer and more arduous. But...
Putting Patients First: High-Tech, High-Value Healthcare The $4 trillion healthcare industry is under intense focus and is rapidly changing, right here, right now. The global pandemic is increasing societal expectations and accelerating shifts in the way healthcare is delivered. Never has there been a better opportunity to do so much good for more people than...
Important news! After carefully monitoring the global COVID-19 situation over recent months and out of concern for the health and well being of all our attendees, sponsors, and staff, we have decided on a different format for this year’s Scrip Awards. For the first time ever, the Scrip Awards is going digital! We are delighted...
Executive leaders from leading next-generation biotechnology companies will provide exclusive insights into their personal quests for funding the growth of innovation. We will explore where they went right, when they took the wrong turn, what they never expected, and how they would chart a different course for the journey. From the initial concept, to building...
Global Health Authorities have long recognized the need to facilitate development and minimize delays in patient access for novel treatments intended for serious and life-threatening disease. Over the past decade, FDA, EMA and PMDA have launched various “expedited programs” to foster collaboration with industry in the delivery of these promising new therapies. This speaker series will...
Please join us for BioNJ’s Sixth Annual Inspiring Women in STEM Conference taking place virtually on December 3 and 4, 2020 from 9:00 a.m.-12:15 p.m. The perfect opportunity to learn from the experiences of successful women who have traveled remarkable journeys, you’re sure to leave with valuable and actionable ideas and guidance. Topics will include: Experience on the Front Line and Impact of...
Each year, CLSA recognizes the achievements and honors excellence of California’s life sciences as it brings together industry leaders for an evening of celebration. Due to the COVID-19 pandemic, CLSA is pivoting the 2020 program to a digital campaign and virtual event. The campaign will begin on Monday, November 30th and run through Thursday, December...
This program is an exclusive forum that unites biopharma executives and industry leaders to discuss relevant trends and biotech developments across Philadelphia, New York, and the surrounding regions. With the presence of large biopharma, emerging startups, medical centers, academic institutions, and financial prowess, NY and Philadelphia are uniquely poised to manage the challenges faced during...
A new product launch, a clinical study, or regulatory submission are all examples of projects in life sciences. In performing their jobs, PMs in the life sciences are taking on more cross-functional responsibilities. And while asked to wear many hats, they must still ensure the final product or program is delivered on time, within budget,...
The premier event in malignant and non-malignant hematology will be all-virtual Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates on the most critical topics in hematology. Program Abstracts Registration Presenter Resources Exhibits Meeting Resources ASH-a-Palooza Past &...
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies,...
The International Conference on Microbiome Engineering (ICME 2020) will bring together leaders and experts from cutting edge fields of microbiome engineering to discuss progress and needs to develop research, technology, and innovation.... Microbiomes consist of diverse microoganisms and viruses that exist in every environment Earth ranging from the deep ocean to human skin. Microbiomes are...
Speakers: Mark Merchant (Genentech), Maryland Franklin (Covance Preclinical Oncology), Karen Rex (Amgen), Willem Overwijk (Nektar Therapeutics), Shelley Ackerman (Bolt Biotherapeutics) Organizers: Gregory Wagner and Betty Chang Date: 2020-12-08 Time: 8:45-13:00 Pacific Time Registration fee: (USD): Location: Online via Zoom Major Sponsor: Vendor show vendors registered to date: Registration: http://www.PBSS.org Registration deadline:2020-12-07 (it will close sooner if the seating cap is reached) About the...
As the tools and technologies that are available to study the skin microbiome become cheaper and more accessible, the fundamental mechanisms that link the skin microbiome with skin health are becoming stronger. The demand for skin microbiome products is advancing rapidly which is only being reflected in the increasing number of products on the market...
Research shows that an effective investor relations program can account for a 30% variance in a company’s valuation. Investor communications is a vital function at any publicly traded company, and an active agenda topic at board meetings. We’ve assembled CFO’s and board members to share their perspective on key investor relations topics that matter to...
Extractable compounds with unknown identities are a common problem when conducting a chemical characterization study in support of medical device biocompatibility. With increasing instrument sensitivity, regulatory scrutiny, and the widespread adoption of the Analytical Evaluation Threshold (AET), unknown compounds are being seen in increasing number in many studies. Many manufacturers struggle to address and mitigate...
Day 1: December 08, 2020 - In Vivo Models and Case Studies with Targeted Therapeutics Symposium Overview and Relevance to Contemporary Issues in Development of Therapeutic Agents for Oncology (Mark Merchant, Genentech) Preclinical Mouse Models for Oncology and Immuno-oncology Applications (Maryland Franklin, Covance-Preclinical Oncology) Preclinical Development of AMG 510, a First-in-human Covalent Inhibitor of KRASG12C...
MedCity INVEST Precision Medicine is an executive program that gathers all sectors of healthcare to provide the most accurate picture of the future of precision medicine. Precision medicine is the next chapter of healthcare and life sciences promising more targeted, effective treatment and cures for common and rare diseases. But with advancements in digital health,...
QB3 SEMINAR: MARTIN BABLER, FORMER CEO, PRINCIPIA BIOPHARMA. "BUILDING A BEST-IN-CLASS PLATFORM FOR IMMUNE-MEDIATED DISEASE" Sanofi recently acquired Principia Biopharma for $3.7 billion. Principia, founded in 2008, built a portfolio of drugs to treat immune-mediated conditions including multiple sclerosis, pemphigus and immune thrombocytopenia purpura, all currently in Phase 3 trials. The portfolio was developed using...
Live from B! An Evening with Giuliana and Bill Rancic Biocom invites you to join us for a year-end “Celebration of Life” This statewide virtual event will feature special celebrity guests who will share a personal and powerful story of courage, interactive live music where you join the band, a unique virtual platform to connect...
Natural killer (NK) cells are highly effective and fast-acting cytolytic cells capable of eradicating target cells with limited adverse effects. Nkarta Therapeutics is focused on developing the next generation of "off-the-shelf" cell therapy product using its proprietary and scalable NK cell expansion platform that allows us to enhance the power, applicability and tolerability of NK...
2020 AACC to Be All Virtual: Due to the threat of the ongoing coronavirus pandemic, AACC has made the pivotal decision to hold the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo as a virtual event on December 13-17, rather than as a live meeting. REGISTER BY NOVEMBER 13 FOR ADVANCED DISCOUNTS The vital...
This meeting brings you the latest antibody science, technologies and partners needed to accelerate next generation antibodies towards commercial success. It is the annual meeting of The Antibody Society, whose members are responsible for designing the scientific program and act as the session Chairs. You can come and network with your fellow Society members. For over...
Whether we like it or not, getting older is a biological reality. But what if we could slow down the aging clock? Are there secrets in our cells to help us age healthier and live longer? Join us on Tuesday, December 15, from 1:00 p.m. to 2:00 p.m. PT, to learn how our scientists are...
Designed to celebrate patients, legislative efforts, and life science industry research and development collaboration, the Holiday Lunch Panel features a discussion focused on the importance of Pennsylvania's recently-passed Newborn Child Testing Act and the wide-ranging benefits of expanded newborn screenings. Register now to join this event and network with other attendees in celebration of our community's commitment...
Join the National Institutes of Health’s National Institute on Aging (NIA) Office of Small Business Research (OSBR), Delaware BioScience Association (Delaware BIO), and New Jersey Biotech (BioNJ) on Thursday, December 17 at 12:30 p.m. ET for a webinar on small business funding opportunities to advance your research to commercialization. Saroj Regmi, Ph.D., OSBR senior program...
The COVID-19 vaccines are finally coming! This extraordinary achievement highlights what scientists in academia and the pharmaceutical and biotech industry have been able to do toward conquering this deadly virus. Come join us at this mini-symposium to learn from our experts about the technical, clinical and implementation aspects of these life-saving vaccines. Agenda: Introduction (10...
